We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Bacterial Toxins Promote Growth of Rare Skin Cancer

By LabMedica International staff writers
Posted on 19 Jan 2016
Toxins secreted by some types of skin bacteria have been shown to promote the growth of the rare skin cancer, cutaneous T-cell lymphoma (CTCL).

CTCL is a class of the immune system cancer non-Hodgkin lymphoma. More...
Unlike most non-Hodgkin lymphomas (which are generally B-cell related), CTCL is caused by a mutation of T-cells. The malignant T-cells in the body initially migrate to the skin, causing various lesions to appear. These lesions change shape as the disease progresses, typically beginning as what appears to be a rash, which can be very itchy, and eventually forming plaques and tumors before metastasizing to other parts of the body. With disease progression, bacteria colonize the compromised skin barrier, and half of CTCL patients die from infection rather than from direct organ involvement by the malignancy. CTCL is a rare form of cancer with only about 50 people in Denmark being diagnosed with the disease annually.

While clinical data indicate that bacteria play a direct role in disease progression, little is known about the mechanisms involved. In a study that was published in the January 6, 2015, online edition of the journal Blood, investigators at the University of Copenhagen (Denmark) defined the role of bacteria in the progression of CTCL.

The investigators demonstrated that bacterial isolates containing staphylococcal enterotoxin-A (SEA) from the affected skin of CTCL patients, as well as recombinant SEA, stimulated activation of STAT3 (signal transducer and activator of transcription 3) and up-regulation of IL-17 (Interleukin-17).

STAT3 is a member of the STAT protein family, which regulates many aspects of cell growth, survival, and differentiation. Malfunction of this signaling pathway is frequently observed in primary tumors and leads to increased angiogenesis and enhanced tumor survival. IL-17 is an immune system protein involved in the signaling cascade that prompts skin cells to multiply in excess numbers.

As SEA induced STAT3 activation and IL-17 expression in malignant T-cells when co-cultured with non-malignant T-cells, it was apparent that SEA induced a type of cell cross-talk as part of a mechanism where SEA-producing bacteria promoted activation of an established oncogenic pathway previously implicated in carcinogenesis.

"We have gained important insight into the processes that activate cancer cells and make them grow. Patients' frequent bacteria infections might not be a mere side effect of the disease—on the contrary, toxins in the bacteria actually "benefit" cancer cells. Our next step is examining whether combating infections can slow down the growth of cancer cells and thus stop the disease," said senior author Dr. Niels Odum, professor of immunology and microbiology at the University of Copenhagen.

Related Links:

University of Copenhagen


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.